LifeStance Health Group, Inc.
LFST Healthcare Medical Care Facilities
LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.
- Revenue
- +25.3%
- EPS
- +2,042.9%
- Free cash flow
- +31.6%
- Total debt
- −5.15%
Quarter to September 2026, against a year earlier
Follow LFST
Alert me
LifeStance Health Group, Inc. (LFST) P/E ratio
As of 5 November 2026, LifeStance Health Group, Inc. (LFST) trades at a P/E ratio of 70.7×. Over the past ten years it has ranged from 0.0× (December 2025) to 301× (January 2026); the current reading is higher than 86% of that period. That is above the Medical Care Facilities industry median of 17.4× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 284× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 63.2× | (21.46%) |
| Jun 2026 | 80.5× | (20.36%) |
| Mar 2026 | 101× | (64.38%) |
| Dec 2025 | 284× | — |
| 23 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SGRY Surgery Partners, Inc. compare | n/m |
| ACHC Acadia Healthcare Company, Inc. compare | n/m |
| AVAH Aveanna Healthcare Holdings Inc. compare | 10.5× |
| OPCH Option Care Health, Inc. compare | 22.6× |
| CON Concentra Group Holdings Parent, Inc. compare | 24.9× |
| CHE Chemed Corporation compare | 25.5× |
| NHC National HealthCare Corporation compare | 28.2× |
| PACS PACS Group, Inc. compare | 28.6× |
| LFST LifeStance Health Group, Inc. | 70.7× |
| Medical Care Facilities industry median | 17.4× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on LFST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement